logo
logo

Partillion Bioscience Corporation Announces Seed Financing, Expanded Board, And New Partnership With Alloy Therapeutics

Sep 26, 2023almost 2 years ago

Round Type

seed

Los AngelesBiotechnology

Investors

Alloy TherapeuticsPaladin CapitalVertical Venture PartnersNd CapitalGeneral InceptionInitiate StudiosAlloy Therapeutics, Inc.

Description

Partillion Bioscience Corporation ("Partillion"), a life science tools company, today announced the closing of a $5 million seed financing round, expansion of its board of directors, and a multiyear agreement with Alloy Therapeutics, Inc. as a Preferred Partner providing antibody discovery services using Partillion's Nanovial technology. Nanovials solve numerous industry challenges as the first microscale test tubes engineered for the isolation and analysis of individual cells that are compatible with standard laboratory equipment. The investment follows the earlier incubation support from venture studio partners Initiate Studios and General Inception

Company Information

Company

Partillion Bioscience

Location

2360 GLENDON AVE.

Los Angeles, California, United States

About

Partillion Bioscience is an early stage life science company aiming to democratize advanced single-cell assays with its award-winning nanovial platform. Our novel platform allows the rapid compartmentalization and analysis of millions of single cells to probe biological function such as secreted proteins. The validated technology underpinning Partillion’s products has been featured in notable journals such as Science Advances, Advanced Functional Materials, and Lab on Chip and received industry accolades, winning the 2020 SLAS Innovation Award.

FundzWatch™ Score

71
Medium Activity

Buyer Intent Analysis

Get personalized insights on buying likelihood

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Related People